Lots of companies make plastics. Lots of companies make plastics for medical devices. Many of ASNB's products are proprietary. They sell them to device companies like Access scientific and CR Bard. This is the key and why I'm here
"Product sales of our biomaterials for the three months ended December 31, 2012 were $440,000 as compared with $179,000 for the prior year period, an increase of $261,000, or 145.8%. The increase is due to the growth in sales from existing and new customers."
If the Powerwand from Access Scientific becomes the standard of the industry, and I think it will, we'll see very large revenue gains here. We'll get a glimpse of what's to come in next month's 10k
"Product sales of our biomaterials for the three months ended December 31, 2012 were $440,000 as compared with $179,000 for the prior year period, an increase of $261,000, or 145.8%. The increase is due to the growth in sales from existing and new customers."
If the Powerwand from Access Scientific becomes the standard of the industry, and I think it will, we'll see very large revenue gains here. We'll get a glimpse of what's to come in next month's 10k
Recent NORD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 07:42:23 PM
- Nordicus Partners Corporation Corporate Update • GlobeNewswire Inc. • 02/06/2026 04:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 06:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 08:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 02:00:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 06:08:32 PM
- NoviThera has initiated the first efficacy animal studies • GlobeNewswire Inc. • 11/13/2025 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2025 08:05:16 PM
- Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats. • GlobeNewswire Inc. • 10/22/2025 01:00:00 PM
- Orocidin develops novel cGMP manufacturing process in collaboration with Syngene • GlobeNewswire Inc. • 10/20/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/14/2025 01:00:24 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 10/14/2025 01:00:23 PM
- Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS • GlobeNewswire Inc. • 10/03/2025 08:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 01:43:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2025 10:07:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 06:45:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 01:38:25 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/05/2025 06:43:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/29/2025 07:21:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 12:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 07:55:13 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/27/2025 01:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 01:00:36 PM

